Insider Trading activities of Dova Pharmaceuticals Inc. (DOVA)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dova Pharmaceuticals Inc. (DOVA) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dova Pharmaceuticals Inc. since year 2005. Table 2 shows the detailed insider transactions of Dova Pharmaceuticals Inc. since 2005. The reporting company's ticker symbol is DOVA. The reporting company's CIK number is 1685071.
The total value of stock buying since 2005 is $31,488,776.
The total value of stock sales since 2005 is $448,280.
The total value of stock option exercises since 2005 is $283,513.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Dova Pharmaceuticals Inc. (DOVA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-08 28,062 $445,343 0 $0 0 $0
2019-07 155,645 $2,540,615 25,420 $393,727 0 $0
2019-06 427,209 $5,682,761 2,387 $33,620 3,500 $29,190
2019-05 0 $0 0 $0 3,668 $26,849
2019-04 0 $0 2,387 $20,933 0 $0
2019-03 68,000 $508,640 0 $0 0 $0
2019-01 0 $0 0 $0 4,583 $33,547
2018-12 468,631 $2,972,152 0 $0 0 $0
2018-08 21,700 $495,410 0 $0 1,832 $13,410
2018-06 471,700 $12,917,425 0 $0 11,000 $80,520
2017-12 0 $0 0 $0 26,809 $99,997
2017-08 46,039 $1,031,030 0 $0 0 $0
2017-07 283,200 $4,895,400 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Dova Pharmaceuticals Inc. insiders (DOVA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-08-09 Manning Paul B (Director) Buy 28,062 15.87 445,343
2019-07-31 Laliberte Kevin (Sr. VP, Product Development) Sale 1,389 15.97 22,182
2019-07-15 Hoitt Jason (Chief Commercial Officer) Sale 7,580 15.77 119,536
2019-07-11 Edelman Joseph (10% Owner) Buy 42,916 16.67 715,409
2019-07-10 Edelman Joseph (10% Owner) Buy 12,354 16.89 208,659
2019-07-09 Edelman Joseph (10% Owner) Buy 29,834 16.61 495,542
2019-07-05 Edelman Joseph (10% Owner) Buy 50,000 16.46 823,000
2019-07-03 Edelman Joseph (10% Owner) Buy 1,705 16.67 28,422
2019-07-02 Zaccardelli David (President & CEO) Sale 10,450 15.97 166,938
2019-07-02 Edelman Joseph (10% Owner) Buy 715 16.14 11,540
2019-07-01 Laliberte Kevin (Sr. VP, Product Development) Sale 1,191 14.17 16,876
2019-07-01 Hahn Mark W (Chief Financial Officer) Sale 1,545 14.17 21,892
2019-07-01 Allen Lee F Md Phd (Chief Medical Officer) Sale 1,957 14.19 27,769
2019-07-01 Jeffs Roger (Director) Sale 1,308 14.17 18,534
2019-07-01 Edelman Joseph (10% Owner) Buy 18,121 14.24 258,043
2019-06-28 Hoitt Jason (Chief Commercial Officer) Sale 2,387 14.09 33,620
2019-06-28 Edelman Joseph (10% Owner) Buy 100,000 14.22 1,422,500
2019-06-27 Edelman Joseph (10% Owner) Buy 327,209 13.02 4,260,261
2019-06-26 Goldman Steven M. (Director) Option Ex 1,750 8.34 14,595
2019-06-20 Goldman Steven M. (Director) Option Ex 1,750 8.34 14,595
2019-05-13 Goldman Steven M. (Director) Option Ex 3,668 7.32 26,849
2019-04-08 Hoitt Jason (Chief Commercial Officer) Sale 2,387 8.77 20,933
2019-03-07 Manning Paul B (Director) Buy 68,000 7.48 508,640
2019-01-02 Goldman Steven M. (Director) Option Ex 4,583 7.32 33,547
2018-12-21 Manning Paul B (Director) Buy 128,500 6.77 869,945
2018-12-20 Stalfort Sean (Director) Buy 31,000 6.26 194,060
2018-12-20 Zaccardelli David (President & CEO) Buy 10,000 6.07 60,700
2018-12-20 Manning Paul B (Director) Buy 266,631 6.17 1,645,113
2018-12-20 Jeffs Roger (Director) Buy 1,169 6.25 7,306
2018-12-19 Hahn Mark W (Chief Financial Officer) Buy 2,500 6.28 15,700
2018-12-19 Jeffs Roger (Director) Buy 28,831 6.22 179,328
2018-08-14 Sapir Alex (President & CEO) Buy 21,700 22.83 495,410
2018-08-13 Goldman Steven M. (Director) Option Ex 1,832 7.32 13,410
2018-06-21 Goldman Steven M. (Director) Buy 5,000 30.22 151,100
2018-06-11 Edelman Joseph (10% Owner) Buy 19,700 29.50 581,150
2018-06-08 Edelman Joseph (10% Owner) Buy 25,000 28.80 719,875
2018-06-07 Manning Paul B (Director) Buy 10,000 27.77 277,750
2018-06-07 Edelman Joseph (10% Owner) Buy 50,000 28.40 1,419,850
2018-06-06 Goldman Steven M. (Director) Option Ex 11,000 7.32 80,520
2018-06-06 Manning Paul B (Director) Buy 17,000 28.85 490,450
2018-06-06 Edelman Joseph (10% Owner) Buy 100,000 28.64 2,864,500
2018-06-05 Goldman Steven M. (Director) Buy 15,000 26.41 396,150
2018-06-05 Manning Paul B (Director) Buy 100,000 26.48 2,648,500
2018-06-05 Edelman Joseph (10% Owner) Buy 100,000 26.30 2,629,700
2018-06-04 Manning Paul B (Director) Buy 20,000 24.39 487,700
2018-06-04 Edelman Joseph (10% Owner) Buy 10,000 25.07 250,700
2017-12-22 Sapir Alex (President & CEO) Option Ex 26,809 3.73 99,997
2017-08-16 Pbm Capital Investments, Llc (10% Owner) Buy 5,000 25.77 128,835
2017-08-15 Pbm Capital Investments, Llc (10% Owner) Buy 20,870 21.77 454,444
2017-08-15 Goldman Steven M. (Director) Buy 20,169 22.20 447,751
2017-07-05 Laliberte Kevin (Sr. VP, Product Development) Buy 6,200 17.00 105,400
2017-07-05 Sapir Alex (President & CEO) Buy 20,100 17.00 341,700
2017-07-05 Pbm Capital Investments, Llc (10% Owner) Buy 150,000 17.00 2,550,000
2017-07-05 Goldman Steven M. (Director) Buy 72,000 18.12 1,305,000
2017-07-05 Allen Lee F Md Phd (Chief Medical Officer) Buy 3,500 17.00 59,500
2017-07-05 Jeffs Roger (Director) Buy 31,400 17.00 533,800

Insider trading activities including stock purchases, stock sales, and option exercises of DOVA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dova Pharmaceuticals Inc. (symbol DOVA, CIK number 1685071) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month